Literature DB >> 7531947

Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice.

A J Pötgens1, N H Lubsen, M C van Altena, J G Schoenmakers, D J Ruiter, R M de Waal.   

Abstract

We studied the expression of the angiogenic factor vascular permeability factor) (VPF, also called vascular endothelial growth factor), in human melanoma cells in vitro and in vivo. Melanoma lines that develop tumors with a low metastatic potential in nude mice were found to have low expression levels of VPF in vitro, and the VPF expression levels in melanoma lines that yield highly metastatic xenografts were high. However, in vivo the correlation between VPF mRNA levels and the frequency of metastasis was lost; in all xenografts equally high levels of VPF mRNA were found, independent of the parental cell line. Hence, in vivo VPF gene expression was upregulated in the low expressing lines. The external factor responsible for this induction may be hypoxia, given that we found that low oxygen tension caused a (reversible) increase in the VPF mRNA levels in otherwise low expressing melanoma lines in vitro. A melanoma line with an inducible VPF expression was engineered into a line with a constitutive VPF expression. In the xenografts from this line a change in the vascular architecture was seen, indicating that the pattern or the level of VPF expression is important for tumor angiogenesis in melanoma xenografts.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7531947      PMCID: PMC1870766     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

Review 1.  Angiogenesis.

Authors:  J Folkman; Y Shing
Journal:  J Biol Chem       Date:  1992-06-05       Impact factor: 5.157

2.  Regulators of angiogenesis: stimulators, inhibitors, and extracellular matrix.

Authors:  M Klagsbrun
Journal:  J Cell Biochem       Date:  1991-11       Impact factor: 4.429

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors.

Authors:  B Berse; L F Brown; L Van de Water; H F Dvorak; D R Senger
Journal:  Mol Biol Cell       Date:  1992-02       Impact factor: 4.138

5.  Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells.

Authors:  G J Dolecki; D T Connolly
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

6.  The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.

Authors:  K A Houck; N Ferrara; J Winer; G Cachianes; B Li; D W Leung
Journal:  Mol Endocrinol       Date:  1991-12

7.  The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

Authors:  C de Vries; J A Escobedo; H Ueno; K Houck; N Ferrara; L T Williams
Journal:  Science       Date:  1992-02-21       Impact factor: 47.728

8.  Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.

Authors:  L Pertovaara; A Kaipainen; T Mustonen; A Orpana; N Ferrara; O Saksela; K Alitalo
Journal:  J Biol Chem       Date:  1994-03-04       Impact factor: 5.157

9.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

10.  The genes coding for the cytoskeletal proteins actin and vimentin in warm-blooded vertebrates.

Authors:  H J Dodemont; P Soriano; W J Quax; F Ramaekers; J A Lenstra; M A Groenen; G Bernardi; H Bloemendal
Journal:  EMBO J       Date:  1982       Impact factor: 11.598

View more
  28 in total

1.  The role of the vascular phase in solid tumor growth: a historical review.

Authors:  D Ribatti; A Vacca; F Dammacco
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 3.  Causes and effects of heterogeneous perfusion in tumors.

Authors:  R J Gillies; P A Schornack; T W Secomb; N Raghunand
Journal:  Neoplasia       Date:  1999-08       Impact factor: 5.715

4.  Anginogenesis of eutopic and ectopic endometria in endometriosis.

Authors:  Yi Liu; Liqun Lü; Guijin Zhu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

5.  Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines.

Authors:  D R Senger
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

6.  Dual VEGF/VEGFR inhibition in advanced solid malignancies: clinical effects and pharmacodynamic biomarkers.

Authors:  Kriti Mittal; Henry Koon; Paul Elson; Pierre Triozzi; Afshin Dowlati; Helen Chen; Ernest C Borden; Brian I Rini
Journal:  Cancer Biol Ther       Date:  2014-05-19       Impact factor: 4.742

7.  HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

Authors:  H E Ryan; J Lo; R S Johnson
Journal:  EMBO J       Date:  1998-06-01       Impact factor: 11.598

8.  Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis.

Authors:  T G Sheidow; P L Hooper; C Crukley; J Young; J G Heathcote
Journal:  Br J Ophthalmol       Date:  2000-07       Impact factor: 4.638

9.  Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.

Authors:  H J Bernsen; P F Rijken; J P Peters; J H Bakker; R H Boerman; P Wesseling; A J van der Kogel
Journal:  J Neurooncol       Date:  1999-09       Impact factor: 4.130

10.  Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.

Authors:  A J Pötgens; M C van Altena; N H Lubsen; D J Ruiter; R M de Waal
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.